Continuous in situ production of CAR T cells from in vivo-transduced HSCs is safe and delays growth of mouse HER2high tumors

Molecular Therapy: Oncology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles